Effects of Glucagon-Like Peptide-1 Receptor Agonists on Upper Gastrointestinal Endoscopy: A Meta-Analysis

This publication has 22 references indexed in Scilit:

• Effects of glucagon-like peptide-1 receptor agonists on gastric mucosal visibility and retained gastric contents during EGD
  Gastrointestinal Endoscopy, 2024
• Glucagon-Like Peptide-1 Receptor Agonists Do Not Increase Aspiration During Upper Endoscopy in Patients With Diabetes
  Clinical Gastroenterology and Hepatology, 2024
• Effects of glucagon-like peptide-1 receptor agonists on upper endoscopy in diabetic and nondiabetic patients
  Gastrointestinal Endoscopy, 2024
• Clinical Outcomes and Safety of Upper Endoscopy While on Glucagon-Like Peptide-1 Receptor Agonists
  Clinical Gastroenterology and Hepatology, 2024
• Association of glucagon-like peptide receptor 1 agonist therapy with the presence of gastric contents in fasting patients undergoing endoscopy under anesthesia care: a historical cohort study
  Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 2024
• Low Incidence of Pulmonary Aspiration During Upper Endoscopy in Patients Prescribed a Glucagon-Like Peptide 1 Receptor Agonist
  Clinical Gastroenterology and Hepatology, 2023
• AGA Rapid Clinical Practice Update on the Management of Patients Taking GLP-1 Receptor Agonists Prior to Endoscopy: Communication
  Clinical Gastroenterology and Hepatology, 2023
• Relationship between perioperative semaglutide use and residual gastric content: A retrospective analysis of patients undergoing elective upper endoscopy
  Journal of Clinical Anesthesia, 2023
• Effects of GLP-1 on appetite and weight
  Reviews in Endocrine and Metabolic Disorders, 2014
• Meta-analysis in clinical trials
  Controlled Clinical Trials, 1986